CSIMarket


An2 Therapeutics Inc   (ANTX)
Other Ticker:  
 

An2 Therapeutics Inc

ANTX's Fundamental analysis








An2 Therapeutics Inc 's sales fell in III. Quarter 2023 from the same quarter a year ago.

Major Pharmaceutical Preparations industry recorded deterioration of revenues by -4.74 %

An2 Therapeutics Inc net loss increased from $-11 millions, to $-17 millions in III. Quarter 2023,

More on ANTX's Growth


An2 Therapeutics Inc
realized a net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 17.35 in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 105.02.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.63.


More on ANTX's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) 5.42

An2 Therapeutics Inc
realized net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 17.35 in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 105.02.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.63.

An2 Therapeutics Inc Price to Book Ratio is at 0.48 lower than Industry Avg. of 78.99. and higher than S&P 500 Avg. of 0.01

More on ANTX's Valuation

  Market Capitalization (Millions $) 66
  Shares Outstanding (Millions) 26
  Employees -
  Revenues (TTM) (Millions $) -
  Net Income (TTM) (Millions $) -60
  Cash Flow (TTM) (Millions $) 4
  Capital Exp. (TTM) (Millions $) -
  Total Debt (Millions $) -
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ -
  Net Income/Employee(TTM) $ -
  Receivable Turnover Ratio (TTM) -
  Tangible Book Value (Per Share $) 5.42

  Market Capitalization (Millions $) 66
  Shares Outstanding (Millions) 26
  Employees -
  Revenues (TTM) (Millions $) -
  Net Income (TTM) (Millions $) -60
  Cash Flow (TTM) (Millions $) 4
  Capital Exp. (TTM) (Millions $) -





  Ratio
   Capital Ratio (MRQ) 8.52
  Total Debt to Equity (MRQ) -
  Tangible Leverage Ratio (MRQ) 0.11
  Asset Turnover Ratio (TTM) -
  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com